Compare J.B.Chemicals with Cipla - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs CIPLA - Comparison Results

J.B.CHEMICALS     Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

CIPLA 
   Change

Cipla is one of the largest pharma companies in the domestic market and has presence in formulations and bulk drugs manufacturing. All the bulk drug manufacturing facilities of the company have been approved by various authorities including the US FD... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS CIPLA J.B.CHEMICALS/
CIPLA
 
P/E (TTM) x 23.1 38.0 60.9% View Chart
P/BV x 4.3 3.9 110.0% View Chart
Dividend Yield % 0.3 0.4 66.4%  

Financials

 J.B.CHEMICALS   CIPLA
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
CIPLA
Mar-19
J.B.CHEMICALS/
CIPLA
5-Yr Chart
Click to enlarge
High Rs363678 53.6%   
Low Rs255484 52.7%   
Sales per share (Unadj.) Rs169.1198.2 85.3%  
Earnings per share (Unadj.) Rs16.618.5 89.6%  
Cash flow per share (Unadj.) Rs23.435.0 66.9%  
Dividends per share (Unadj.) Rs2.003.00 66.7%  
Dividend yield (eoy) %0.60.5 125.3%  
Book value per share (Unadj.) Rs172.5186.3 92.6%  
Shares outstanding (eoy) m83.57805.70 10.4%   
Bonus/Rights/Conversions BBESOP-  
Price / Sales ratio x1.82.9 62.4%   
Avg P/E ratio x18.631.4 59.4%  
P/CF ratio (eoy) x13.216.6 79.5%  
Price / Book Value ratio x1.83.1 57.5%  
Dividend payout %12.016.2 74.4%   
Avg Mkt Cap Rs m25,827468,031 5.5%   
No. of employees `0003.822.6 16.7%   
Total wages/salary Rs m2,51128,565 8.8%   
Avg. sales/employee Rs Th3,747.47,053.1 53.1%   
Avg. wages/employee Rs Th665.71,261.5 52.8%   
Avg. net profit/employee Rs Th367.8659.1 55.8%   
INCOME DATA
Net Sales Rs m14,135159,710 8.9%  
Other income Rs m3664,766 7.7%   
Total revenues Rs m14,501164,475 8.8%   
Gross profit Rs m2,17830,973 7.0%  
Depreciation Rs m57013,263 4.3%   
Interest Rs m351,684 2.1%   
Profit before tax Rs m1,94020,791 9.3%   
Minority Interest Rs m0-172 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5525,695 9.7%   
Profit after tax Rs m1,38714,924 9.3%  
Gross profit margin %15.419.4 79.5%  
Effective tax rate %28.527.4 104.0%   
Net profit margin %9.89.3 105.0%  
BALANCE SHEET DATA
Current assets Rs m10,470124,266 8.4%   
Current liabilities Rs m2,74937,715 7.3%   
Net working cap to sales %54.654.2 100.8%  
Current ratio x3.83.3 115.6%  
Inventory Days Days5591 60.9%  
Debtors Days Days7895 81.9%  
Net fixed assets Rs m5,811105,190 5.5%   
Share capital Rs m1671,611 10.4%   
"Free" reserves Rs m14,248148,511 9.6%   
Net worth Rs m14,416150,123 9.6%   
Long term debt Rs m038,301 0.0%   
Total assets Rs m17,649239,633 7.4%  
Interest coverage x56.613.3 424.0%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x0.80.7 120.2%   
Return on assets %8.16.9 116.3%  
Return on equity %9.69.9 96.8%  
Return on capital %13.711.8 115.7%  
Exports to sales %034.7 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA55,419 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m6,16457,410 10.7%   
Fx outflow Rs m1,33419,041 7.0%   
Net fx Rs m4,82938,368 12.6%   
CASH FLOW
From Operations Rs m1,23116,911 7.3%  
From Investments Rs m-208-16,687 1.2%  
From Financial Activity Rs m-595-3,487 17.1%  
Net Cashflow Rs m427-3,451 -12.4%  

Share Holding

Indian Promoters % 55.4 16.0 346.3%  
Foreign collaborators % 0.3 20.8 1.4%  
Indian inst/Mut Fund % 3.4 12.2 27.8%  
FIIs % 3.9 23.7 16.5%  
ADR/GDR % 0.0 1.1 -  
Free float % 37.0 26.2 141.2%  
Shareholders   30,437 161,166 18.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   DIVIS LABORATORIES  WOCKHARDT  AUROBINDO PHARMA  FRESENIUS KABI ONCO.  GLENMARK PHARMA  

Compare J.B.CHEMICALS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End Flat; Power and Telecom Stocks Witness Buying(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

CIPLA Announces Quarterly Results (4QFY20); Net Profit Down 35.1% (Quarterly Result Update)

May 19, 2020 | Updated on May 19, 2020

For the quarter ended March 2020, CIPLA has posted a net profit of Rs 2 bn (down 35.1% YoY). Sales on the other hand came in at Rs 44 bn (down 0.6% YoY). Read on for a complete analysis of CIPLA's quarterly results.

CIPLA Announces Quarterly Results (3QFY20); Net Profit Up 9.4% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, CIPLA has posted a net profit of Rs 4 bn (up 9.4% YoY). Sales on the other hand came in at Rs 44 bn (up 9.1% YoY). Read on for a complete analysis of CIPLA's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

CIPLA Announces Quarterly Results (2QFY20); Net Profit Up 31.2% (Quarterly Result Update)

Nov 14, 2019 | Updated on Nov 14, 2019

For the quarter ended September 2019, CIPLA has posted a net profit of Rs 5 bn (up 31.2% YoY). Sales on the other hand came in at Rs 44 bn (up 9.6% YoY). Read on for a complete analysis of CIPLA's quarterly results.

CIPLA 2018-19 Annual Report Analysis (Annual Result Update)

Sep 9, 2019 | Updated on Sep 9, 2019

Here's an analysis of the annual report of CIPLA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of CIPLA. Also includes updates on the valuation of CIPLA.

More Views on News

Most Popular

These 5 Smallcaps Deserve a Place in Your Coffee Can Portfolio(Profit Hunter)

Jul 28, 2020

When it comes to quality stocks, doing less is more.

Before You Buy Your First Electric Vehicle Consider Buying this Stock(Profit Hunter)

Jul 29, 2020

As competition intensifies in the electric vehicle space, only few will create huge wealth over the years.

How to Buy Gold and Silver(Fast Profits Daily)

Jul 27, 2020

In this video I'll show you how to buy bullion the right way.

Large Opportunities Are Coming Our Way

Aug 5, 2020

Kenneth Andrade tells us why stocks will bounce back strongly and what he's bullish on.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Aug 7, 2020 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 5-YR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS